A novel prognostic risk score was created to evaluate the efficacy of eplerenone across different risk categories in patients with systolic heart failure and mild symptoms.
Absolute Event Rate: 0% vs 0%
Our objective was to create a simple prognostic risk score for patients with systolic heart failure and mild symptoms. We then assessed the efficacy of eplerenone across different categories of risk.
Collier et al. (Wed,) reported a other. A novel prognostic risk score was created to evaluate the efficacy of eplerenone across different risk categories in patients with systolic heart failure and mild symptoms.